Table 5.
By-visit achievement of target blood pressurea by study and for the merged full analysis set
| CONFIDENCE II (N = 1182) |
PROTECT I (N = 866) |
STH I (N = 528) |
STH II (N = 362) |
Merged FAS (N = 2938) |
|
|---|---|---|---|---|---|
| Achievement of target BP, yes, n (%)b | |||||
| Visit 2 |
N = 1171 635 (54.2) |
N = 864 504 (58.3) |
N = 500 328 (65.6) |
N = 345 173 (50.1) |
N = 2880 1640 (56.9) |
| Visit 3 |
N = 982 702 (71.5) |
N = 740 592 (80.0) |
N = 433 347 (80.1) |
N = 288 207 (71.9) |
N = 2443 1848 (75.6) |
| LOCF |
N = 1177 802 (68.1) |
N = 866 676 (78.1) |
N = 527 408 (77.4) |
N = 362 256 (70.7) |
N = 2932 2142 (73.1) |
a234 diabetic patients (CONFIDENCE I: n = 71, PROTECT I: n = 122, STH I: n = 24, STH II: n = 17) were considered to have controlled BP at Visit 1, according to the European Society of Hypertension/European Society of Cardiology (ESH/ESC) guidelines, and were excluded from consideration in the target BP analyses
bTarget BP was defined as <140/90 mmHg for non-diabetic patients and < 140/85 mmHg for diabetic patients; calculated based on the total number of patients with available information (SBP, DBP and diabetic status)
BP blood pressure, FAS full analysis set, LOCF last observation carried forward, STH Shake the Habit